Conclusion: Benazepril has a good therapeutic efficacy on chronic pneumocardial disease with cardiac failure.
结论:贝那普利对慢性肺心病心力衰竭有良好的治疗效果。
Results Serum total cholesterol were effectively decreased in 3 groups after therapy. Combination of benazepril and valsartan therapy reduced triglyceride effectively.
结果治疗后各组血清总胆固醇水平显著降低;联合治疗组甘油三酯水平显著降低(P苯那普利组和联合治疗组对低密度脂蛋白、载脂蛋白B水平的影响大于缬沙坦组(P
Objective: To explore the effect of Benazepril on the levels ofMMP-9 and CRP in patients with ACS.
目的:探讨苯拉普利对ACS患者血清MMP-9及CRP水平的影响。